Observation On The Curative Effect Of Mongolian Medicine "Goyu-13 Taste Pill" On Post-stroke Depression

Objective: in this study,the Mongolian medicine gaoyou-13 wei pill was used to treat post-stroke depression patients.By comparing with the western medicine group,the therapeutic effect of Mongolian medicine on post-stroke depression was observed,and the improvement of depression degree was observed to promote the recovery of neurological function.Methods: from January 2019 to January 2020,60 patients with post-stroke depression who met the dual diagnostic criteria of stroke and depression were randomly divided into treatment group and control group with 30 cases in each group.Both groups were given routine treatment of stroke.The treatment group took gaoyou-13 wei pill,11 pills,warm water before going to bed.In the control group,Flupentixol and melitracen were taken orally,two tablets a day,in the morning and at noon.The course of treatment in both groups was 4 weeks.Methods: observe and compare the changes of Hamilton Depression Scale,Mongolian medical symptom score and nhiss score before,2 weeks after treatment and 4 weeks after treatment.After the treatment,the scores were statistically processed,and the relevant data were analyzed by spss22.0 software.Results: ⑴comparison of depression improvement: the total effective rate of the treatment group was 80%,and the total effective rate of the control group was 76.7%.Before treatment,there was no significant difference in HAMD score between the two groups(P > 0.05).The difference of HAMD scores between the two groups was statistically significant(P < 0.05),indicating that the therapeutic effect of the control group was higher than that of the treatment group;the difference of HAMD scores between the two groups was not statistically significant(P > 0.05),indicating that the two groups were equally effective in improving depression after 4 weeks of treatment.(2)Mongolian medicine syndrome improvement comparison: the total effective rate of the treatment group is 80%,the total effective rate of the control group is 70%.Before treatment,there was no significant difference between the two groups(P > 0.05).After 4 weeks of treatment,the scores of Mongolian medicine syndrome in the two groups were compared,the difference was statistically significant(P > 0.05),indicating that the therapeutic effect of the treatment group in improving Mongolian medicine syndrome after 4 weeks was higher than that of the control group.(3)comparison of improvement of neurological deficit: the total effective rate of the treatment group was 73.3%,and that of the control group was 63.3%.Before treatment,there was no significant difference in NIHSS scores between the two groups(P > 0.05),which was comparable.After 4 weeks of treatment,NIHSS scores of the two groups were compared,the difference was statistically significant(P > 0.05),indicating that both groups could improve the neurological deficit of patients with post-stroke depression.Conclusion: Mongolian medicine gaoyou-13 can improve the degree of depression in patients with post-stroke depression,improve the symptoms of Mongolian medicine,promote the recovery of neurological function,provide scientific basis for the treatment of stroke depression in Mongolian medicine,and provide certain reference value for the future clinical work.